Preferred Label : Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7;
NCIt synonyms : Stage IVA Epidermoid Carcinoma of Oropharynx; Stage IVA Squamous Cell Carcinoma of the Oropharynx; Stage IVA Epidermoid Carcinoma of the Oropharynx; Stage IVA Oropharyngeal Epidermoid Carcinoma; Stage IVA Oropharynx Epidermoid Carcinoma; Stage IVA Oropharynx Squamous Cell Carcinoma; Stage IVA Squamous Cell Carcinoma of Oropharynx; Stage IVA Oropharyngeal Squamous Cell Carcinoma;
NCIt related terms : Stage IVA Oropharyngeal Throat Squamous Cell Cancer;
NCIt definition : Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3,
N2, M0); (T4a, N2, M0). T4a: Tumor with moderately advanced local disease. Tumor invades
the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible.
Mucosal extension to lingual surface of epiglottis from primary tumors of the base
of the tongue and vallecula does not constitute invasion of larynx. T1: Tumor 2 cm
or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in
greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension
or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis.
N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension.
N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not
more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none
more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes,
none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.);
Neoplastic status : Malignant;
Origin ID : C6141;
UMLS CUI : C1336356;
Disease excludes abnormal cell
Has associated anatomic sites
Semantic type(s)
concept_is_in_subset
disease_excludes_finding
disease_has_abnormal_cell
disease_has_finding
disease_has_normal_cell_origin
disease_has_normal_tissue_origin
disease_has_primary_anatomic_site
disease_is_stage
disease_mapped_to_gene
disease_may_have_molecular_abnormality